Plasma samples from secondary progressive multiple sclerosis patients were also screened in order to explore the feasibility of these arrays for broad-scale profiling of autoantibody reactivity.
Analysis on these near proteome-wide microarrays was complemented with analysis on HuProt™ Human Proteome protein microarrays.